Find Your Daily Voice
Trumbull-Monroe
Easton Redding
Serving Trumbull, Monroe, Easton, and Redding
Friday, jan 3
32°
Follow
News
Schools
Business
Obituaries
Police & Fire
Weather
Lifestyle
Politics
Sports
Traffic
Real Estate
Tags
Jobs
Shop
Support Us
Trumbull-Monroe
Easton Redding
Follow
Find Your Daily Voice
News
Schools
Business
Obituaries
Police & Fire
Weather
Lifestyle
Politics
Sports
Traffic
Real Estate
Tags
Jobs
Shop
Support Us
Home
About us
All sites
Advertise with us
Contact us
Terms of use
Privacy policy
Code of ethics
Site Map
© 2025 Cantata Media
32°
Friday, jan 3
News
Covid-
19: FDA To Announce J&J Vaccine Has Been Linked To Rare Disorder, Report Says
The Food and Drug Administration is reportedly getting ready to announce a warning that the Johnson & Johnson COVID-19 vaccine has been linked to a rare autoimmune disorder. The Washington Post reported on Monday, July 12, that the Centers for Disease Control and Prevention said about 100 reports of Guillain-Barré syndrome have been detected among people who have received the Johnson & Johnson vaccine in the United States. More than 12.8 million doses of the Johnson & Johnson vaccine have been administered in the U.S., the CDC reported. The Mayo Clinic said…
News
Covid-
19: New Variant May Be More Resistant To Vaccines Than Other Strains, Scientists Say
A new strain of the COVID-19 virus may be more resistant to vaccines than other variants, scientists are now warning. The C.37 strain, known as the Lambda variant, was first identified in Peru in December 2020, when it accounted for less than one percent of new cases. It now accounts for about 80 percent of new infections in Peru and has spread to about 27 countries in the last month, according to a report in the Financial Times. The World Health Organization said the strain carries a number of mutations that may have prompted potential increased transmissibility or possible increased resi…
News
Covid-
19: New Study Reveals How Long Protection From Pfizer, Moderna Vaccines Could Last
Claims that booster shots could be required in several months for those receiving the Moderna and Pfizer COVID-19 vaccine may have been overblown, according to new reports. New findings in a study published this week showed that both COVID-19 vaccines have shown a “persistent” immune response to the virus that could potentially last years. The last looming question is how effective the vaccines are against variants of the virus, specifically the more transmissible Delta strain that has become dominant in the US and is present in 49 states. Related story - COVID-19: Parts Of US With Low Va…
Lifestyle
Covid-
19: CDC Reveals Percentage Of Americans Who Haven't Gotten Second Dose
A significant number of Americans who received their first COVID-19 shot have missed their second dose, causing concern as the number of new cases from the Delta variant grows, according to the Centers for Disease Control and Prevention (CDC). The CDC said this week that more than 10 percent of Americans have received just one dose and opted to skip the second vaccine, which could prove problematic as the more transmissible Delta COVID-19 variant continues to rapidly spread and become more dominant. According to the CDC, just 88 percent of those who received one dose of the Moderna or Pfize…
News
Covid-
19: New
Us-m
ade Vaccine Has 90 Percent Efficiency Rate, Can Be Stored In Refrigerators
An American biotech company announced that it has concluded the latest phase of clinical trials for its COVID-19 vaccine, which has proven to be highly effective. Novavax announced on Monday, June 14 that its vaccine has an overall efficacy rate of 90.4 percent in a Phase 3 trial that took place across the United States and Mexico. The Novavax vaccine can be stored in standard refrigerators, making it easier to distribute. Additional analysis of the trial is ongoing, according to the company, and will be submitted to peer-reviewed journals for publication. The company said that the vacc…
News
Covid-
19: Moderna Asks FDA To Approve Vaccines For Those Ages 12 To 17
Moderna has requested an emergency use authorization from the Food and Drug Administration (FDA) for its COVID-19 vaccine in adolescents between the ages of 12 and 17. The company announced that clinical trials have shown that the vaccine has a 93 percent efficacy rate among adolescents, and has been proven to be safe. If approved, it would be the second COVID-19 vaccine authorized for adolescents, joining the Pfizer-BioNTech vaccine, which was given the green light for use earlier this month. In their study, Moderna found no cases of COVID-19 in participants who received two doses of th…
News
Covid-
19: Vaccine 'Safe, Highly Effective' In Kids 12-17, Moderna Says, Will Seek FDA Approval
Moderna’s COVID-19 vaccine has proven effective and safe for adolescents and teens between the ages of 12 and 17, the company announced, as it prepares to seek federal authorization. The company announced that clinical trials have shown that the vaccine has a 93 percent efficacy rate among adolescents, and has been proven to be safe. Moderna officials said that they plan to apply for federal approval from the Food and Drug Administration (FDA) to use the vaccine in that age group in June. If approved, it would be the second COVID-19 vaccine authorized for adolescents, joining the Pfizer-Bi…
News
Covid-
19: CDC Releases Brand-New Data On Hospitalized, Fatal Vaccine Breakthrough Cases
The Centers for Disease Control & Prevention (CDC) has released brand-new data on the number of people who have been hospitalized or died despite being fully vaccinated for COVID-19. To be fully vaccinated, two weeks or more must have passed since they received the second dose of the Pfizer or Moderna vaccine or the single-dose Johnson & Johnson vaccine. As of Monday, May 17, more than 123 million people in the United States had been fully vaccinated. During that time, the CDC said it received a total of 1,949 reports from 47 states and territories of vaccine brea…
News
Covid-
19: New Time Frame Provided For When Vaccine Booster Shots May Be Necessary
Executives and experts at the center of COVID-19 pandemic response are now providing a more specific possible time frame for when Americans who were first to receive a vaccine dose may need to take a booster shot. Pfizer CEO Albert Bourla, speaking during an Axios event, said that the data he has reviewed supports the notion "that likely there will be a need for a booster somewhere between eight and 12 months" after the initial vaccination regime. That means those who were among the first to get a vaccine shot in mid to late December 2020 or early January 2021 would likely need a booster sh…
Business
Covid-
19: These Retailers Are Allowing Maskless Shopping For Fully Vaccinated
With the Centers for Disease Control and Prevention (CDC) and most states loosening up mask-wearing restrictions, many retailers are following suit and are enacting new policies for customers and employees. The CDC said last week that fully vaccinated people do not need to wear a mask or stay 6 feet apart from others in most cases, whether indoors or outdoors. People are considered fully vaccinated two weeks after they receive the second dose of the Pfizer or Moderna vaccines or the single dose of Johnson & Johnson. The following mandates are in place at thes…
Sports
Covid-
19: Details Emerge On Vaccine Brand Taken By Star Shortstop, Seven Other Infected Yankees
Despite being fully vaccinated for COVID-19, eight members of the New York Yankees still tested positive for the virus after receiving the one-dose Johnson & Johnson shot. The eight are: starting shortstop Gleyber Torres, third base coach Phil Nevin, first base coach Reggie Willits, pitching coach Matt Blake, and four support staffers. Related story - COVID-19: Fully Vaccinated TV Host, Star Shortstop, Seven Other NY Yankees Test Positive According to the initial clinical trial results, the single-dose Johnson & Johnson vaccine has proven to be 72 percent effective against COVID-1…
News
Covid-
19: CDC Issues Brand-New Guidance On Mask-Wearing Indoors
The Centers for Disease Control and Prevention (CDC) is easing indoor mask-wearing guidance for Americans who are fully vaccinated for COVID-19. On Thursday afternoon, May 13, CDC Director Dr. Rochelle Walensky announced the new guidance at a White House briefing, saying that anyone who has received both shots of the Pfizer or Moderna vaccine, or the one-dose Johnson & Johnson shot can safely stop wearing masks indoors, except under some circumstances. The new guidance calls for continued mask-wearing in more crowded indoor spaces such as on mass transportation, hospitals, prisons, or …
Next Page
Archive
32°
